ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)
China
· Delayed Price · Currency is CNY 10.27
-0.02 (-0.19%)
Apr 30, 2025, 3:00 PM CST
SHA:600479 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 3,634 | 3,630 | 3,721 | 3,955 | 3,599 | 3,586 | Upgrade
|
| Other Revenue | - | - | 77.38 | 71.35 | 65.12 | 40.7 | Upgrade
|
| Revenue | 3,634 | 3,630 | 3,798 | 4,026 | 3,664 | 3,627 | Upgrade
|
| Revenue Growth (YoY) | -5.34% | -4.44% | -5.66% | 9.89% | 1.02% | 2.89% | Upgrade
|
| Cost of Revenue | 1,934 | 1,946 | 2,051 | 2,296 | 2,038 | 2,038 | Upgrade
|
| Gross Profit | 1,700 | 1,683 | 1,748 | 1,731 | 1,626 | 1,589 | Upgrade
|
| Selling, General & Admin | 1,151 | 1,140 | 1,167 | 1,172 | 1,128 | 1,109 | Upgrade
|
| Research & Development | 221.21 | 220.2 | 149.07 | 113.82 | 108.72 | 104.06 | Upgrade
|
| Other Operating Expenses | 23.81 | 22.56 | 38 | 37.93 | 35.11 | 34.68 | Upgrade
|
| Operating Expenses | 1,403 | 1,387 | 1,372 | 1,326 | 1,271 | 1,250 | Upgrade
|
| Operating Income | 297.62 | 296.16 | 376.42 | 404.85 | 354.6 | 338.86 | Upgrade
|
| Interest Expense | -0.22 | -1.11 | -1.67 | -2.21 | -2.11 | -2.25 | Upgrade
|
| Interest & Investment Income | 54.11 | 51.11 | 68.86 | 30.7 | 33.64 | 52.46 | Upgrade
|
| Other Non Operating Income (Expenses) | -4.44 | -4.16 | -4.72 | -4.26 | -2.93 | 1.6 | Upgrade
|
| EBT Excluding Unusual Items | 347.06 | 342 | 438.9 | 429.08 | 383.19 | 390.67 | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.43 | 0.63 | -1.6 | -1.3 | 4.72 | 2.08 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.5 | 0.5 | -0.94 | 0.17 | 33.11 | 5.32 | Upgrade
|
| Asset Writedown | -7.73 | -7.82 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 24.06 | 17.85 | 12.4 | 26.52 | Upgrade
|
| Pretax Income | 343.25 | 335.31 | 460.42 | 445.81 | 433.42 | 424.58 | Upgrade
|
| Income Tax Expense | 29.33 | 32.7 | 65.4 | 58.67 | 58.68 | 64.38 | Upgrade
|
| Earnings From Continuing Operations | 313.92 | 302.61 | 395.02 | 387.15 | 374.74 | 360.21 | Upgrade
|
| Minority Interest in Earnings | -76.21 | -71.85 | -74.61 | -84.64 | -72.68 | -63.14 | Upgrade
|
| Net Income | 237.71 | 230.76 | 320.41 | 302.51 | 302.06 | 297.07 | Upgrade
|
| Net Income to Common | 237.71 | 230.76 | 320.41 | 302.51 | 302.06 | 297.07 | Upgrade
|
| Net Income Growth | -26.33% | -27.98% | 5.92% | 0.15% | 1.68% | 0.94% | Upgrade
|
| Shares Outstanding (Basic) | 412 | 414 | 423 | 428 | 418 | 419 | Upgrade
|
| Shares Outstanding (Diluted) | 412 | 414 | 423 | 428 | 418 | 419 | Upgrade
|
| Shares Change (YoY) | -2.35% | -2.11% | -1.31% | 2.30% | -0.01% | -0.00% | Upgrade
|
| EPS (Basic) | 0.58 | 0.56 | 0.76 | 0.71 | 0.72 | 0.71 | Upgrade
|
| EPS (Diluted) | 0.58 | 0.56 | 0.76 | 0.71 | 0.72 | 0.71 | Upgrade
|
| EPS Growth | -24.57% | -26.43% | 7.32% | -2.11% | 1.69% | 0.94% | Upgrade
|
| Free Cash Flow | 403.4 | 351.45 | 399.13 | 699.04 | 413.69 | 445.14 | Upgrade
|
| Free Cash Flow Per Share | 0.98 | 0.85 | 0.94 | 1.63 | 0.99 | 1.06 | Upgrade
|
| Dividend Per Share | - | - | 0.350 | 0.350 | 0.600 | 1.000 | Upgrade
|
| Dividend Growth | - | - | - | -41.67% | -40.00% | 100.00% | Upgrade
|
| Gross Margin | 46.79% | 46.38% | 46.02% | 42.98% | 44.38% | 43.81% | Upgrade
|
| Operating Margin | 8.19% | 8.16% | 9.91% | 10.05% | 9.68% | 9.34% | Upgrade
|
| Profit Margin | 6.54% | 6.36% | 8.43% | 7.51% | 8.24% | 8.19% | Upgrade
|
| Free Cash Flow Margin | 11.10% | 9.68% | 10.51% | 17.36% | 11.29% | 12.27% | Upgrade
|
| EBITDA | 375.36 | 374.08 | 455.08 | 473.88 | 418.84 | 399.75 | Upgrade
|
| EBITDA Margin | 10.33% | 10.31% | 11.98% | 11.77% | 11.43% | 11.02% | Upgrade
|
| D&A For EBITDA | 77.74 | 77.92 | 78.66 | 69.03 | 64.24 | 60.89 | Upgrade
|
| EBIT | 297.62 | 296.16 | 376.42 | 404.85 | 354.6 | 338.86 | Upgrade
|
| EBIT Margin | 8.19% | 8.16% | 9.91% | 10.05% | 9.68% | 9.34% | Upgrade
|
| Effective Tax Rate | 8.55% | 9.75% | 14.21% | 13.16% | 13.54% | 15.16% | Upgrade
|
| Revenue as Reported | 3,634 | 3,630 | 3,798 | 4,026 | 3,664 | 3,627 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.